Morpholine carboxamide prokineticin receptor antagonists

Details for Australian Patent Application No. 2006322067 (hide)

Owner Merck & Co., Inc.

Inventors Melamed, Jeffrey Y.; Thompson, Wayne J.

Agent Spruson & Ferguson

Pub. Number AU-A-2006322067

PCT Pub. Number WO2007/067511

Priority 60/742,770 06.12.05 US; 60/856,984 06.11.06 US; 60/830,242 12.07.06 US

Filing date 4 December 2006

Wipo publication date 14 June 2007

International Classifications

A61K 31/535 (2006.01) - having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Event Publications

5 June 2008 PCT application entered the National Phase

  PCT publication WO2007/067511 Priority application(s): WO2007/067511

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

4 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006322073-dsRNAs as influenza virus vaccine adjuvants or immuno-stimulants

2006322060-Lactam compounds and methods of using the same